Saturday 17 October 2026
Export CRKN’s income statement to Excel — free account
Crown Electrokinetics Corp.
CRKN Basic Materials Specialty Chemicals
Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.00
0.01
−100.00%
Follow CRKN
| Dec '18 | Mar '19 | Dec '19 | Mar '20 | Mar '21 | Dec '21 | Mar '22 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 0.04 | 0.00 |
Altman Z-Score |
— | — | — | — | — | — | — | — | 87.57 | 52.49 |
P/S ratio |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 3,691.35 | 64.12 |
Altman Z″-Score (non-manufacturers) |
(97.90) | (97.90) | — | (397.55) | — | — | — | — | (53.95) | (13.78) |
P/FCF ratio |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | — | 0.00 | — | — | — | — | (214.74) | (196.78) |
P/B ratio |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 199.68 | 56.79 |
Price to Tangible BV |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 283.43 | 59.91 |
EV/Sales |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 3,688.57 | 63.46 |
EV/EBITDA |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | — | 0.00 | — | — | — | — | (57.76) | (68.76) |
EV/FCF |
0.00 | 0.00 | — | 0.00 | — | — | — | — | (50.91) | (51.39) |
Quick Ratio |
0.03 | 0.03 | — | 0.01 | 16.37 | 9.23 | 0.17 | 0.17 | 0.30 | 1.72 |
Current Ratio |
0.05 | 0.05 | 0.00 | 0.01 | 16.74 | 10.27 | 0.30 | 0.30 | 0.50 | 2.13 |
Net Debt/EBITDA |
0.06 | 0.06 | 0.00 | 0.01 | 0.93 | 0.00 | (0.04) | 0.06 | 0.12 | 0.62 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 20.73% | 0.00% | 0.00% | 1.94% |
Debt/Equity |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 2.58 | 0.00 | 0.00 | 0.03 |
Asset Turnover |
0.86 | 0.75 | 0.00 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.89 |
Operating CF/Net income |
0.38 | 0.38 | (0.89) | 0.11 | 0.16 | — | 0.78 | 0.78 | 0.54 | 0.56 |
Capex/Depreciation |
(0.10) | (0.10) | (0.02) | (0.02) | (0.58) | — | 0.00 | (0.76) | (0.20) | (1.92) |
Interest Coverage |
(2.33) | (2.33) | — | (5.23) | (6.05) | — | — | (2,158.29) | (2.05) | (24.27) |
| 220.51% | 126.55% | 0.00% | 185.49% | (846.73%) | 0.00% | (301.95%) | (2,711.32%) | (1,139.24%) | (241.21%) | |
| (729.34%) | (638.31%) | (2,086.22%) | (3,018.67%) | (455.10%) | 0.00% | (176.95%) | (218.06%) | (368.06%) | (145.89%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (937.46%) | 0.00% | 0.00% | 0.00% | (333.54%) | (163.47%) |
Return on Tangible Assets |
113.82% | 113.82% | (75,621.26%) | 133.47% | (273.21%) | 0.00% | 44,906.25% | 766.81% | (2,429.16%) | (155.75%) |
Average Days of Receivables |
17.93 | 17.93 | — | 0.00 | — | — | — | — | 198.01 | 99.23 |
Research and Development Expense of Revenue |
141.05% | 141.07% | — | 1,826.10% | 0.00% | — | 0.00% | 0.00% | 1,833.33% | 17.09% |
Selling, General and Administrative Expense of Revenue |
354.81% | 354.81% | 0.00% | 5,491.80% | 0.00% | — | 0.00% | 0.00% | 9,851.63% | 101.75% |
Intangible Assets out of Total Assets |
0.41 | 0.41 | 0.95 | 0.60 | 0.09 | 0.18 | 0.24 | 0.24 | 0.15 | 0.03 |
Share Based Compensation of Revenue |
0.00% | 201.01% | — | 4,496.20% | 0.00% | — | — | 0.00% | 466.67% | 26.65% |
Graham Net Nets |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 0.00 | 0.01 |
Graham Number |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 5,990.76 | 0.00 |
Earnings Yield |
0.00% | 0.00% | — | 0.00% | — | — | — | — | 2,701.76% | (2,953.22%) |
Free Cash Flow Yield |
0.00% | 0.00% | — | 0.00% | — | — | — | — | (1.96%) | (1.93%) |
Revenue per Share |
0.00 | 0.05 | — | 0.02 | 0.00 | — | 0.00 | 0.00 | 0.56 | 0.33 |
Operating CF per Share |
0.00 | (0.15) | 0.00 | (0.25) | (0.74) | — | (38.33) | 0.00 | (59.40) | (0.31) |
Capex per Share |
0.00 | (0.01) | 0.00 | (0.01) | (0.18) | — | 0.00 | 0.00 | (7.99) | (0.10) |
Free Cash Flow per Share |
0.00 | (0.16) | 0.00 | (0.26) | (0.93) | — | (38.33) | 0.00 | (67.39) | (0.41) |
Cash per Share |
0.00 | 0.01 | — | 0.01 | 1.73 | 0.00 | 2.83 | 0.00 | 3.89 | 0.23 |
Shareholders Equity per Share |
0.00 | (0.32) | — | (1.69) | 1.87 | 0.00 | 1.82 | 0.00 | 17.19 | 0.38 |
Interest Debt per Share |
— | 0.00 | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | (0.32) | — | (1.69) | 1.87 | 0.00 | 1.82 | 0.00 | 17.19 | 0.38 |
Free Cash Flow |
(1.72) | (1.72) | 8.53 | (1.07) | (8.22) | — | (11.14) | (11.95) | (18.33) | (24.33) |
Working Capital |
(3.88) | (3.88) | 0.01 | (7.29) | 14.71 | 6.15 | (3.28) | (3.28) | (1.91) | 12.51 |
Capital Expenditures |
(0.11) | (0.11) | (0.03) | (0.03) | (1.63) | — | (0.81) | (0.81) | (2.17) | (6.14) |
Net Current Asset Value |
(3.88) | (3.88) | 0.01 | (7.29) | 14.71 | 6.15 | (4.65) | (4.65) | (2.98) | 10.85 |
EV/EBIT |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 0.00 | 0.00 |
Capex to Sales |
0.22 | 0.22 | 0.00 | 0.27 | 0.00 | — | — | 0.00 | 14.20 | 0.31 |
Price to Operating Income |
0.00 | 0.00 | — | 0.00 | — | — | — | — | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
10.26 | 10.26 | 0.00 | 13.49 | 13.47 | 0.00 | 0.31 | 0.76 | 3.42 | 0.38 |
Cash ROIC |
52.33% | 52.34% | 0.00% | 15.49% | (25.78%) | 0.00% | (410.01%) | (884.68%) | (319.58%) | (66.42%) |
Accounts Receivable Turnover |
0.00 | 20.35 | — | 0.00 | — | — | — | — | 2.84 | 7.24 |
Accounts Payable Turnover |
2.02 | 1.19 | — | 0.70 | 0.13 | 0.00 | 1.63 | 0.00 | 0.79 | 5.89 |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | 0.00 | — | 0.00 | — | 0.00 | 0.00 |
Average Days of Payables |
307.93 | 307.81 | — | 743.19 | 1,011.29 | 0.00 | 316.68 | 0.00 | 586.19 | 97.21 |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | 0.00 | — | 0.00 | — | 0.00 | 0.00 |
Average Receivables |
— | 0.02 | — | — | — | — | — | — | 0.05 | 2.72 |
Average Payables |
0.30 | 0.52 | — | 0.89 | 0.77 | 0.32 | 0.61 | 0.87 | 1.18 | 3.47 |
Average Assets |
0.59 | 0.67 | 0.46 | 0.32 | 8.96 | 13.59 | 8.12 | 6.59 | 8.06 | 22.26 |
Average Common Equity |
(1.95) | (3.39) | — | (5.18) | 4.81 | 12.79 | 4.76 | 0.53 | 2.60 | 13.46 |
Columns are period end dates